Skip to main content

What the FDA labels say about taking them together

Methylene blue and morphine

Morphine's FDA label of July 13, 2026 names methylene blue in its drug interactions section; methylene blue's label does not name morphine itself but warns about its class (Opioids (opioid agonists)). The morphine label: “The concomitant use of opioids with other drugs that affect the serotonergic neurotransmitter system has resulted in serotonin syndrome.”

Check it at the source: the methylene blue FDA label on DailyMed (effective May 28, 2025, American Regent, Inc.); the morphine FDA label on DailyMed (effective July 13, 2026, Bryant Ranch Prepack).

What does the methylene blue label say about morphine?

Methylene blue's label does not name morphine itself; it warns about its class (Opioids (opioid agonists)):

Methylene blue label, boxed warning

SEROTONIN SYNDROME WITH CONCOMITANT USE OF SEROTONERGIC DRUGS AND OPIOIDS PROVAYBLUE may cause serious or fatal serotonergic syndrome when used in combination with serotonergic drugs and opioids.

Methylene blue label, boxed warning

SEROTONIN SYNDROME WITH CONCOMITANT USE OF SEROTONERGIC DRUGS AND OPIOIDS See full prescribing information for complete boxed warning.

Source: FDA drug label (PROVAYBLUE), NDA204630 (Provepharm Sas), as published by American Regent, Inc., effective May 28, 2025 (SPL set 4f6848e5-35ed-4046-b13c-3032b5ba3232), via openFDA; the full label on DailyMed

What does the morphine label say about methylene blue?

Morphine label, drug interactions

Serotonergic Drugs Clinical Impact: The concomitant use of opioids with other drugs that affect the serotonergic neurotransmitter system has resulted in serotonin syndrome. … inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).

Source: FDA drug label (Ms Contin, NDA019516), Rhodes Pharmaceuticals LLC, effective August 14, 2026 (SPL set c354b3bf-86c0-4bb8-8b1f-be2164942698), via openFDA

Source: FDA drug label (Morphine sulfate), ANDA078761 (Sun Pharm Inds Ltd), as published by Bryant Ranch Prepack, effective July 13, 2026 (SPL set 595243fe-a4b1-479a-99d6-a084a4181891), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

11Methylene blue generic labelers
22Morphine generic labelers
Methylene blueMorphine
Labeled forn/aPain
Boxed warningYesYes
Pharmacy cost (NADAC)n/a$0.226 per tablet 15 mg tablet
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?